A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...
MedPage Today on MSN
Targeted drug for advanced pancreatic cancer sparks early enthusiasm
The early results showed that 15 of 41 evaluable patients had objective responses and 32 had stable disease with the ...
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...
The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...
The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback